Opinion|Videos|July 29, 2024
Decision-Making in CLL: The Role of Real-World Evidence
A discussion on therapeutic decision-making in CLL and the role of real-world evidence.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How do you integrate real-world evidence into your clinical decision-making process for BTK inhibitors in CLL?
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Boston Panel Confronts Access and Coordination Gaps in Obesity Care
5